The agreement also supports Saudi Arabia’s efforts to expand local maritime manufacturing capabilities, promote knowledge transfer and advance the development of a more competitive International ...

In eukaryotes, ribosome biogenesis initiates within the nucleolus, a hallmark multilayered compartment of the nucleus. Structures of pre-ribosomes have been characterized ex situ, but their assembly ...

Revolution Medicines recently made history with the approval of its RAS inhibitor Rasonque for advanced pancreatic cancer. But behind RevMed is an entire field of biotechs working to broaden the reach ...

The U.S. Food and Drug Administration (FDA) has approved daraxonrasib, an oral multi-selective RAS(ON) inhibitor, for adults with metastatic pancreatic adenocarcinoma who have received at least one ...

The FDA approved daraxonrasib, the first targeted therapy for metastatic pancreatic adenocarcinoma, citing a survival benefit vs chemotherapy. The FDA approved daraxonrasib (Rasonque; Revolution ...

The FDA has approved the first RAS-targeted therapy for metastatic pancreatic cancer, offering a new treatment option for patients with previously treated disease. Daraxonrasib (Rasonque, Revolution ...

Unmanned Surface Vessel Division 12 (Sea Hunter) and 13 (Sea Hunter) conduct unit level training underway in San Diego Bay, California, May 1, 2025. US Navy photo The Navy’s portfolio acquisition ...

Boards often hire senior leaders from outside the company to strengthen their CEO succession bench. When internal options appear limited, companies recruit accomplished division presidents, regional ...

August 03, 2026 - Lateral hiring has become one of the primary ways law firms pursue growth. In a recent survey of firm leaders, opens new tab by co-author James Barclay's firm Passle, 52% named it a ...

Bringing in the rainmaker is the visible move; resourcing that rainmaker to actually succeed is the one that determines whether the hire ever pays off, and it is precisely where most firms fall short.